Chitsanoor Setthakit, Somsri Sangdao, Panburana Panyu, Mungthin Mathirut, Ubalee Ratawan, Emyeam Maliwan, Jongwutiwes Somchai, Sattabongkot Jetsumon, Udomsangpetch Rachanee
Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Graduate Programme in Biomedical Science, Faculty of Allied Health Sciences, Thammasart University, Pathumthani, Thailand.
Malar J. 2017 Mar 27;16(1):131. doi: 10.1186/s12936-017-1781-4.
To date, human peripheral blood mononuclear cells (PBMCs) have been used mainly in immune stimulation assays and the interpretation of data can be influenced by the previous immunological history of donors and cross reactivity with other infectious agents. Resolving these limitations requires an alternative in vitro model to uncover the primary response profiles.
A novel in vitro model of mononuclear cells (MNCs) generated from haematopoietic stem cells (HSCs) was developed and these cells were then co-cultured with various antigens from Plasmodium falciparum and Plasmodium vivax to investigate the response of naïve immune cells to malaria antigens by flow cytometry.
In vitro stimulation of naïve lymphocytes showed that CD4 and CD8 T lymphocytes were significantly reduced (P < 0.01) by exposure to lysates of infected erythrocytes or intact erythrocytes infected with P. falciparum. The depletion was associated with the expression of CD95 (Fas receptor) on the surface of T lymphocytes. Maturation of T lymphocytes was affected differently, showing elevated CD3CD4CD8 and CD3CD4CD8 T lymphocytes after stimulation with cell lysates of P. falciparum and P. vivax, respectively. In addition, antigen presenting monocytes and dendritic cells derived from haematopoietic stem cells showed impaired HLA-DR expression as a consequence of exposure to different species of malaria parasites.
These results suggest that naïve mononuclear cells differentiated in vitro from HSCs could provide a valid model for the assessment of immunity. P. falciparum and P. vivax malaria parasites could modulate various populations of immune cells starting from newly differentiated mononuclear cells.
迄今为止,人类外周血单个核细胞(PBMCs)主要用于免疫刺激试验,数据解读可能受到供体既往免疫史以及与其他感染因子交叉反应的影响。解决这些局限性需要一种替代的体外模型来揭示初始反应谱。
建立了一种由造血干细胞(HSCs)生成单核细胞(MNCs)的新型体外模型,然后将这些细胞与恶性疟原虫和间日疟原虫的各种抗原共培养,通过流式细胞术研究初始免疫细胞对疟疾抗原的反应。
对初始淋巴细胞的体外刺激显示,暴露于恶性疟原虫感染的红细胞裂解物或完整红细胞后,CD4和CD8 T淋巴细胞显著减少(P < 0.01)。这种减少与T淋巴细胞表面CD95(Fas受体)的表达有关。T淋巴细胞的成熟受到不同影响,分别用恶性疟原虫和间日疟原虫的细胞裂解物刺激后,CD3CD4CD8和CD3CD4CD8 T淋巴细胞升高。此外,源自造血干细胞的抗原呈递单核细胞和树突状细胞由于暴露于不同种类的疟原虫而显示HLA-DR表达受损。
这些结果表明,体外由造血干细胞分化而来的初始单个核细胞可为免疫评估提供一个有效的模型。恶性疟原虫和间日疟原虫可从新分化的单个核细胞开始调节各种免疫细胞群体。